| Product Name | MF | CAS | Details |
|---|
| Valsartan Methyl Ester | C7H5Cl2NO4S | 62971-57-7 | Details |
| Vitamin B6 Impurity 82 | C21H42O2 | 1120-28-1 | Details |
| Ezetimibe (SSR)-Isomer | C16H11FN2O3 | 775304-64-8 | Details |
| 1,3-dimethyl-32-nitrosourea | C7H10N2O | 700376-84-7 | Details |
| Varenicline Impurity D | C16H12N2O3 | 2786607-23-4 | Details |
| Baricitinib Impurity I | C17H22N4O | 160177-67-3 | Details |
| Vitamin B6 Impurity 83 | C19H33NO5 | 1215342-36-1 | Details |
| N-Nitroso Furosemide | C12H24N2O7 | 1143516-05-5 | Details |
| Linagliptin Impurity CD10117 | C17H29NO4 | 1346601-75-9 | Details |
| Ezetimibe (SSR)-Isomer | C2H4N2O2 | 628-36-4 | Details |
| Phthalamic Acid | C21H26O4 | 3103-17-1 | Details |
| DL-Methionine Sulfoxide | C22H23ClO8 | 1298086-37-9 | Details |
| (R)-Amlodipine | C8H12N2O2S | 2101302-47-8 | Details |
| Cilnidipine Impurity 37 | C57H49F4N13O9S2 | 2814571-35-0 | Details |
| N-Nitroso Furosemide | C6H10N2O3 | 4515-18-8 | Details |
| Nintedanib Impurity 54 | C15H11NO2 | 2142-01-0 | Details |
| Cilnidipine Impurity 38 | C24H48O2 | 2433-97-8 | Details |
| Noradrenaline Impurity 41 | C29H40O7 | 2408495-96-3 | Details |
| Tofacitinib Impurity FD+DX | C26H31ClN2O8S | 150566-71-5 | Details |
| Cilnidipine Impurity 41 | C6H10N2O3 | 65445-62-7 | Details |
| N-Nitroso Furosemide | 2932441-73-9 | Details |
| Varenicline Impurity D | C9H12O4S | 1507299-93-5 | Details |
| (R)-Amlodipine | C6H7N | 6921-28-4 | Details |
| Tofacitinib Citrate | C23H27ClO7 | 1632287-34-3 | Details |
| Ezetimibe (SSR)-Isomer | C29H42NO7+ | 1100676-15-0 | Details |
| N-Nitroso Furosemide | C20H22N4O6S | 58306-30-2 | Details |
| Rosuvastatin EP Impurity A | C13 H12 F2 N4 O | 1966991-73-0 | Details |
| Nintedanib Impurity 56 | C16H18O5 | 80681-42-1 | Details |
| Tofacitinib Impurity FD+DX | C17H16BrIO2 | 2452301-13-0 | Details |
| Vitamin B6 Impurity 86 | C9H14O4 | 67950-95-2 | Details |
| Fulvestrant Impurity I | C6H10O6 | 1198-69-2 | Details |
| DL-Methionine Sulfoxide | C8H14N2O5S2 | 25779-79-7 | Details |
| Noradrenaline Impurity 47 | C6H12N4O4 | 16337-02-3 | Details |
| Fulvestrant Impurity I | C19H17ClN6O2 | 1297537-33-7 | Details |
| Tofacitinib Impurity FD+DX | C17H18FN3O3 | 526204-10-4 | Details |
| Noradrenaline Impurity 46 | C6H10O6 | 52153-09-0 | Details |
| Tofacitinib Impurity FD+DX | C12H14ClN | 1179031-47-0 | Details |
| 2-hydroxy-29-(methylthio)butanamide | C7H6IN5 | 2095840-86-9 | Details |
| Vitamin B6 Impurity 79 | C22H30N6O2 | 2410284-89-6 | Details |
| Linagliptin Impurity CD10119 | C21H25ClFN3O3 | 112886-58-5 | Details |
| Linagliptin Impurity CD10122 | C14H18FNO4 | 78543-08-5 | Details |
| Baricitinib Impurity I | C19H19ClN6O2 | 2407645-49-0 | Details |
| Vitamin B6 Impurity 85 | C6H9ClO3 | 54527-68-3 | Details |
| Rosuvastatin EP Impurity A | C9H9N3O | 129137-93-5 | Details |
| Nintedanib Impurity 59 | C8H11ClN2O2 | 87330-70-9 | Details |
| Rosuvastatin EP Impurity A | C18H25N5O3 | 1675248-18-6 | Details |
| Tofacitinib Citrate | C13H13ClN4 | 1297537-41-7 | Details |
| Fulvestrant Impurity I | C43H79N3O13 | 1118767-16-0 | Details |
| Tofacitinib Citrate | CH4N2O | 624-84-0 | Details |
| Fulvestrant Impurity I | C20H17N3O4 | 91421-43-1 | Details |
| Noradrenaline Impurity 44 | C22H23ClF3N | 2469242-96-2 | Details |
| Ezetimibe (SSR)-Isomer | C21H18N2O5 | 19685-10-0 | Details |
| (R)-Amlodipine | C13H21NO3 | 62572-93-4 | Details |
| Phthalamic Acid | C19H32O2 | 301-00-8 | Details |
| Vitamin B6 Impurity 81 | C15H15N | 92850-02-7 | Details |
| Fulvestrant Impurity I | C18H24N4O | 127472-42-8 | Details |
| Rosuvastatin EP Impurity A | C9H10O | 122-00-9 | Details |
| Lactate tetramer | C6H11NO2 | 10232-92-5 | Details |
| Baricitinib Impurity I | C22H19ClN6 | 700361-47-3 | Details |
| Lactate tetramer | C28H47NO5 | 70779-06-5 | Details |
| Valsartan Methyl Ester | C16H20N2O4 | 1416134-63-8 | Details |
| Nintedanib Impurity 57 | C21H27ClO7 | 1938090-31-3 | Details |
| Varenicline Impurity D | C21H29N6O7P | 2055343-42-3 | Details |
| 2-hydroxy-34-(methylthio)butanamide | C19H38O2 | 112-61-8 | Details |
| Tofacitinib Citrate | C6H9N3O3 | 877-89-4 | Details |
| 2-hydroxy-35-(methylthio)butanamide | C21H25ClFN3O3 | 112886-56-3 | Details |
| DL-Methionine Sulfoxide | C10H14O | 89-83-8 | Details |
| Varenicline Impurity D | C17H14F3N3O3S | 170571-00-3 | Details |
| Baricitinib Impurity I | C16H10ClFN2O3 | 2787819-29-6 | Details |
| DL-Methionine Sulfoxide | C13H11NO3 | 376592-93-7 | Details |
| Phthalamic Acid | C7H9ClN2 | 59681-66-2 | Details |
| Linagliptin Impurity CD10121 | C48H58N6O8 | 936623-90-4 | Details |
| Valsartan Methyl Ester | C22H20F2N4O2 | 1369764-02-2 | Details |
| Vitamin B6 Impurity 84 | C17H32N4O7 | 138884-14-7 | Details |
| Tofacitinib Impurity FD+DX | C15H19NO9S | 14152-97-7 | Details |
| Ezetimibe (SSR)-Isomer | C6H8N2O3 | 1401584-94-8 | Details |
| N-Nitroso Furosemide | C23H46O2 | 929-77-1 | Details |
| Fulvestrant Impurity I | C17H34O2 | 112-39-0 | Details |
| Tofacitinib Citrate | C22H25ClO8 | 1298086-28-8 | Details |
| DL-Methionine Sulfoxide | C13H21NO5S | 2733250-84-3 | Details |
| Valsartan Methyl Ester | C9H10N2 | 2876-08-6 | Details |
| N-Nitroso Furosemide | C17H19NO5S | 2476465-06-0 | Details |
| Varenicline Impurity D | C8H11N | 103-67-3 | Details |
| 1,3-dimethyl-34-nitrosourea | C30H37F2NO3Si2 | 272778-13-9 | Details |
| Cilnidipine Impurity 35 | C5H9NO3S | 15312-11-5 | Details |
| 2-hydroxy-33-(methylthio)butanamide | C26H34FN3O6S | 851440-19-2 | Details |
| Linagliptin Impurity CD10115 | C30H30F4N4O4 | 917389-29-8 | Details |
| (R)-Amlodipine | C10H10ClFO | 3110-52-9 | Details |
| Phthalamic Acid | C4H10ClNO3 | 5874-57-7 | Details |
| 1,3-dimethyl-31-nitrosourea | C33H29ClN4O2 | 885045-90-9 | Details |
| Ezetimibe (SSR)-Isomer | C9H13NO2 | 133481-09-1 | Details |
| Deubutafrazine Impurity | C17 H22 N4 O | 107007-95-4 | Details |
| Tofacitinib Impurity FD+DX | C13H20N2O2 | 923035-05-6 | Details |
| (R)-Amlodipine | C34H30N2O6S | 22204-24-6 | Details |
| Ezetimibe (SSR)-Isomer | C6H4N2O4 | 2047-49-6 | Details |
| Rosuvastatin EP Impurity A | C17H14F3N3O3S | 2356153-95-0 | Details |
| Tofacitinib Citrate | C21H25N5O8S2 | 82956-11-4 | Details |
| Rosuvastatin EP Impurity A | 2285346-38-3 | Details |
| Lactate tetramer | C51H56N16O4 | 2463617-49-2 | Details |
| 1,3-dimethyl-30-nitrosourea | CH3NO | 75-12-7 | Details |
| Product Total： Product Page： | ||||
| 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 | ||||